CG Oncology, Inc. (CGON) — Stock Score Summary

CG Oncology, Inc. (CGON) has a MoatMap StockRank of 47/100 based on Quality (38/100), Value (35/100), and Momentum (61/100) factor scores. The current signal is HOLD. CG Oncology is a clinical-stage biotech company with no established commercial revenues. It fails our Terry Smith and Warren Buffett lenses, which require proven profitability and high ROIC.

CG Oncology, Inc. is a clinical-stage biotechnology company focused on developing novel oncolytic immunotherapies for cancer. Its lead candidate, cretostimogene grenadenorev, is designed to selectively replicate in and destroy cancer cells while stimulating an anti-tumor immune response. The company's potential competitive moat lies in its innovative oncolytic virus platform targeting specific cancer types, positioning it as a specialized player in the immuno-oncology space.

Key Financial Metrics

Price$56.67
Market Cap$5.4B
P/E (Forward)-20.18
Price/Book4.52
Return on Equity-20.8%
Return on Invested Capital-25.1%
Debt/Equity0.69
Gross Margin0.0%
Operating Margin-6130.1%
Revenue Growth1982.7%
Free Cash Flow$-106M

CG Oncology, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is CG Oncology, Inc.’s (CGON) StockRank?
MoatMap’s StockRank for CG Oncology, Inc. (CGON) is 47/100, with a Hold signal. It is a composite of Quality (38), Value (35), and Momentum (61) factor ranks across MoatMap’s 19,000+ stock universe.
Does CG Oncology, Inc. have an economic moat?
CG Oncology, Inc. (CGON) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is CG Oncology, Inc. a buy, hold, or sell?
MoatMap’s current signal for CG Oncology, Inc. (CGON) is Hold, based on a StockRank of 47/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is CG Oncology, Inc. in?
CG Oncology, Inc. (CGON) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksCGON deep dive reportAI ChampionsHow we score stocksSense-check another stock